FDA Inspection
Innovative Fertility CenterInnovative Fertility Center – FDA Inspection, Dec 17, 2024
Record Details
This FDA Inspection record concerns Innovative Fertility Center, with an inspection on December 17, 2024, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 86a3a92f-431c-42e5-86ba-d642c63ef5e3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256820
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.55(b)(3)Name and address on summary
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Innovative Fertility Center
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 29, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 1, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 18, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 9, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Innovative Fertility Center
- FDA Inspection 1088727 - 2019-03-29
- FDA Inspection 984454 - 2016-09-01
- FDA Inspection 866858 - 2014-02-18
- FDA Inspection 807808 - 2012-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.